Implications for Management of PET Amyloid Classification Technology
NCT02778971
·
clinicaltrials.gov ↗
COMPLETED
Status
41
Enrollment
OTHER
Sponsor class
Conditions
Mild Cognitive Impairment
Dementia
Alzheimer's Disease
Interventions
DRUG:
[18F]Flutemetamol
Sponsor
University of Utah